Clinical Report: Evaluation of the Left Atrioventricular Coupling Index via Echocardiography
Overview
The Left Atrioventricular Coupling Index (LACI) is an echocardiographic parameter for assessing diastolic function. Challenges in technical standardization and implementation hinder its clinical application.
Background
The assessment of cardiac function traditionally relies on left ventricular ejection fraction (LVEF), which may not adequately detect diastolic dysfunction, especially in heart failure with preserved ejection fraction (HFpEF). The LACI offers a new approach by evaluating inter-chamber interactions rather than single-chamber function. Clinical adoption of LACI is limited by technical variability and a lack of standardized measurement protocols.
Data Highlights
No numerical or trial data provided in the source material.
Key Findings
LACI is defined as the ratio of left atrial end-diastolic volume to left ventricular end-diastolic volume.
Two-dimensional echocardiography is optimal for screening, while real-time three-dimensional echocardiography (RT-3DE) provides the highest consistency with cardiovascular magnetic resonance.
3DE-LACI has shown independent prognostic value in cardiac amyloidosis.
Speckle-tracking echocardiography (STE) aids in mechanistic exploration but requires standardization of algorithms.
AI-assisted analysis shows potential but needs multicenter validation.
Key limitations include the absence of cross-platform calibration and fragmented reference values.
Clinical Implications
Clinicians should be aware of the limitations in the standardization and clinical application of LACI.
Conclusion
LACI's clinical utility is currently limited by technical challenges that need to be addressed for broader implementation.
